Vioxx Recall Information

I am interested in evaluating potential claims of severe injury caused from the use of Vioxx.

Vioxx Withdrawn After Study Suggests It May Double the Risk of Heart Attack

Increased risk of serious cardiovascular events, including heart attacks and strokes, found in test of arthritis drug.

Sept. 30, 2004 – In a stunning announcement today, drug-maker Merck & Co. announced the withdrawal of the popular anti-inflammatory drug Vioxx from the market due to a study they were conducting that shows patients taking the drug face twice the risk of heart attack compared to those in the test taking a placebo. The FDA, that approved the drug in 1999, also issued a public health advisory and news release. It is used by many senior citizens for arthritis.

“Vioxx is a prescription COX-2 selective, non-steroidal anti-inflammatory drug (NSAID) that was approved by FDA in May 1999 for the relief of the signs and symptoms of osteoarthritis, for the management of acute pain in adults, and for the treatment of menstrual symptoms. It is also approved for the relief of the signs and symptoms of rheumatoid arthritis in adults and children,” says the FDA.

The health advisory said, “The risk that an individual patient taking Vioxx will suffer a heart attack or stroke related to the drug is very small. Patients who are currently taking Vioxx should contact their physician for guidance regarding discontinuation and alternative therapies.'

More information here.

For a free and confidential evaluation, call toll free 1-800-500-0729 or email David B. Shapiro, attorney at law at DShapiroLaw@aol.com .

Please note that I will not consider a person to be a client unless I have accepted the case, and we have a signed written Contingent Fee Agreement.